Human papillomavirus types in invasive cervical cancer specimens from Turkey

International Journal of Gynecological Pathology

Volumn 28, Issue 6, 2009, Pages 541-548

  Usubütün, Alp ^a   Alemany, Laia ^b,c   Küçükali, Türkan ^a   Ayhan, Ali ^a   Yüce, Kunter ^a   De Sanjosé, Silvia ^b,c   Font, Rebeca ^b,c   Lloveras, Belen ^b   Klaustermeier, Joellen ^b,c   Quint, Wim ^d   Muñoz, Nubia ^b   Bosch, Francesc Xavier ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d DDL DIAGNOSTIC LABORATORY   (Netherlands)

Author keywords

Cervical cancer; Epidemiology; HPV; Turkey

Indexed keywords

BETA GLOBIN; PARAFFIN; VIRUS DNA; VIRUS VACCINE;

ADENOSQUAMOUS CARCINOMA; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INVASION; CONTROLLED STUDY; DNA DETERMINATION; ENDOMETRIUM CARCINOMA; ENZYME IMMUNOASSAY; FEMALE; GENE AMPLIFICATION; GENETIC ANALYSIS; GENOTYPE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN TISSUE; NEUROENDOCRINE TUMOR; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROPREVALENCE; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; TURKEY (REPUBLIC); UNDIFFERENTIATED CARCINOMA; UTERINE CERVIX CANCER; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS TYPING; WART VIRUS; CROSS-SECTIONAL STUDY; PAPILLOMAVIRUS INFECTION; UTERINE CERVIX TUMOR; VIROLOGY;

CROSS-SECTIONAL STUDIES; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; TURKEY; UTERINE CERVICAL NEOPLASMS;

EID: 73949089808     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3181aaba0d     Document Type: Article

References (33)

1. Ferlay J, Bray F, Pisani P, et al. Globocan 2002 cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No.5 version 2.0. Lyon: IARC Press; 2004.
2. Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine 2006;24S3:S3/11-25.
3. Cancer Incidence in Turkey (1998-2002). In: Curado MP, Edwards B, Shin HR, et al, eds. Cancer Incidence in Five Continents, Vol.IX. Lyon, IARC: IARC Scientific Publications No. 160; 2007.
4. Castellsagué X, de Sanjosé S, Aguado T, et al. HPV and Cervical Cancer in the World. 2007 Report. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Vaccine 2007;25:C110.
5. Muñoz N, Bosch FX, de Sanjose S, et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 1992;52:743-749
6. Bosch FX, Manos MM, Muñoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
7. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19
8. Muñoz N, Castellsagué X, Berrington A, et al. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006;24S3:S3/1-10.
9. Castellsagué X, Muñoz N. Chapter 3: cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 2003; 31:20-28
10. Palefsky JM, Holly EA. Chapter 6: immunosupression and coinfection with HIV. J Natl Cancer Inst Monogr 2003;31:41-46
11. Smith JS, Herrero R, Bosetti C, et al; International Agency for Research on Cancer (IARC) Multicentric Cervical Cancer Study Group. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 2002;94:1604-1613
12. Smith JS, Bosetti C, Muñoz N, et al; International Agency for Research on Cancer (IARC) Multicentric Cervical Cancer Study Group. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer 2004;111:431-439
13. Muñoz N, Bosch FX, de Sanjosé S, et al; International Agency for Research on Cancer (IARC) Multicentric Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-527 (Pubitemid 36159887)
14. Bernard HU, Callejas-Macias IE, Dunn ST. Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer 2006;118:1071-1076
15. Gravitt PE, Kovacic MB, Herrero R, et al. High load for most human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. Int J Cancer 2007;121: 2787-2793
16. Bernard HU. The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J Clin Virol 2005;32 (suppl 1):S1-6.
17. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci 2006;110:525-541
18. Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a metaanalysis. Br J Cancer 2003;88:63-73.
19. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007; 121:621-632
20. Cuzick J, Arbyn M, Sankaranarayanan R, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008;26S:K29-41.
21. Schiller JT, Villa L, Hildesheim A, et al. An update of HPV VLP vaccine clinical trial results. Vaccine 2008;26S: K53-61.
22. Kleter B, van Doorn LJ, Ter Schegget J, et al. Novel shortfragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998;153:1731-1739
23. Tuncer S, Ustaçelebi S. Servikal biyopsi örneklerinde insan papilloma virusleri tip 16 ve 18'in polimeraz zincir reaksiyonu ile saptanmasi. Flora 1996;1:40-44.
24. Ozcelik B, Serin IS, Gokahmetoglu S, et al. Human papillomavirus frequency of women at low risk of developing cervical cancer: a preliminary study from a Turkish university hospital. Eur J Gynaecol Oncol 2003;24:157-159
25. Ozturk S, Kaleli I, Kaleli B, et al. Investigation of human papillomavirus DNA in cervical specimens by hybrid capture assay. Mikrobiyol Bul 2004;38:223-232
26. Onan MA, Taskiran C, Bozdayi G, et al. Assessment of human papilloma viral load of archival cervical intraepithelial neoplasia by real-time polymerase chain reaction in a Turkish population. Eur J Gynaecol Oncol 2005;26:632-635
27. Ergunay K, Misirlioglu M, Pinar F, et al. Investigation of human papillomavirus DNA in cervical samples with cytological abnormalities and typing of the virus. Mikrobiyol Bul 2007;41:219-226
28. Inal MM, Köse S, Yildirim Y, et al. The relationship between human papillomavirus infection and cervical intraepithelial neoplasia in Turkish women. Int J Gynecol Cancer 2007;17: 1266-1270
29. Ozgul N, Cil AP, Bozdayi G, et al. Staining characteristics of p16INK4a: is there a correlation with lesion grade or HR-HPV positivity? J Obstet Gynaecol Res 2008;34:865-871
30. Tavassoli FA, Devilee P, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press; 2003.
31. Breslow NE, Day NE. Statistical methods in cancer research. Vol.I-The analysis of case-control studies. IARC Sci Publ 1980;32:5-338.
32. Muñoz N, Bosch FX, Castellsagué X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004; 111:278-285
33. Pirog EC, Kleter B, Olgac S, et al. Prevalence of human papillomavirus DNA indifferent histological subtypes of cervical adenocarcinoma. Am J Pathol 2000;157:1055-1061